What is Cardiofaciocutaneous / Cfc Syndrome

Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder characterized by a distinctive facial appearance, heart defects, and skin abnormalities. It is caused by mutations in genes within the RAS/MAPK pathway, which affects how cells grow and divide, leading to complex developmental challenges.

What are the primary symptoms of Cardiofaciocutaneous syndrome?

The clinical presentation of Cardiofaciocutaneous syndrome typically involves three main areas: heart (cardio), facial features (facio), and skin (cutaneous). Individuals often experience intellectual disability, developmental delays, and failure to thrive during infancy. The 36 members of the DiseaseMaps community with Cardiofaciocutaneous syndrome often report shared experiences regarding unique developmental milestones and the need for multidisciplinary care.

How does Cardiofaciocutaneous syndrome affect the body?

The pathophysiology of Cardiofaciocutaneous syndrome involves mutations in the BRAF, MAP2K1, MAP2K2, or KRAS genes. These mutations lead to the following systemic impacts:

• Cardiac: Pulmonary valve stenosis, atrial septal defects, and hypertrophic cardiomyopathy.


• Dermatological: Sparse or curly hair, dry/scaly skin (hyperkeratosis), and ichthyosis.


• Craniofacial: High forehead, down-slanting eyes, and a low nasal bridge.


• Gastrointestinal: Significant feeding difficulties and gastroesophageal reflux are common in early childhood.

How common is Cardiofaciocutaneous syndrome?

Cardiofaciocutaneous syndrome is an extremely rare condition; while exact global prevalence is difficult to determine, it is estimated to affect fewer than 1 in 100,000 individuals. It affects males and females equally across all ethnic groups. Most cases occur sporadically as a result of a de novo (new) mutation in the individual, meaning it is rarely inherited from parents.

How is Cardiofaciocutaneous syndrome distinguished from similar conditions?

Cardiofaciocutaneous syndrome is part of a group of disorders known as "RASopathies," which include Noonan syndrome and Costello syndrome. While they share overlapping features, Cardiofaciocutaneous syndrome is uniquely identified by the specific combination of severe skin manifestations and a distinct facial profile, often confirmed through targeted genetic panel testing.

Next steps

• Consult a clinical geneticist to confirm the diagnosis through molecular genetic testing.


• Schedule routine screenings with a pediatric cardiologist and dermatologist.


• Connect with the DiseaseMaps community to share experiences with other families.


• Engage with early intervention services to support developmental milestones.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cardiofaciocutaneous syndrome.


• Orphanet: Rare disease database entry for CFC syndrome.


• OMIM (Online Mendelian Inheritance in Man): Entry #115150.


• CFC International: Patient advocacy and support foundation.